Solunumun Klinik Değerlendirilmesi
Yazarlar (6)
Gizem Kurada
Elif Kaya Argadal
Leman Gökçenur Aydın
Ayşe Yılmaz
Zahide Doğanay
| Makale Türü |
Özgün Makale
(Uluslararası alan indekslerindeki dergilerde yayınlanan tam makale)
|
||
| Dergi Adı | |||
| Makale Dili | – | Basım Tarihi | 09-2022 |
| Makale Linki | https://books.google.com/books?hl=en&lr=&id=5veTEAAAQBAJ&oi=fnd&pg=PA47&dq=info:gcahXbmYitEJ:scholar.google.com&ots=NxRAf0xoX4&sig=r504V0lb17-6ke9nSGCuQhYa454 | ||
| UAK Araştırma Alanları |
Anesteziyoloji ve Reanimasyon
|
||
| Özet |
| Introduction he development of extracorporeal life support technologies, especially extracorporeal membrane oxygenation (ECMO) systems, has allowed new horizons to be opened in the treatment of heart and lung failure cases. These treatment systems can be used as a bridge to recovery in the short and medium term, a bridge to longer treatment, or a decision bridge for a detailed evaluation of clinical prognosis (1).Artificial lungs or membranous oxygenators are simply mechanical devices in which blood is exposed to oxygen through a gas-permeable membrane. Like normal lungs, control is provided by the amount of gas exchange, device geometry, blood composition and many similar parameters. In this way, they can be used in a long process from hours to weeks (2). A significant benefit in favor of ECMO in the treatment of acute respiratory distress syndrome (ARDS) was reported in the 2009 statement of the randomized'CESAR study'conducted by Extracorporeal Life Support Organization (ELSO) worldwide (3). Especially in the H1N1 pandemic that broke out in 2009, ECMO was used in patients with acute respiratory distress syndrome (ARDS) and came to the fore with its reduction in mortality (4). In addition, in the results of the'EOLIA study'published in 2018, a decrease in mortality was found in patients using ECMO due to ARDS compared to conventional treatment (5). According to April 2021 ELSO data, more than 172.000 ECMOs have been used in the world and ECMO with neonatal respiratory cause (87% survival rate) is the most successful indication (6). |
| Anahtar Kelimeler |
